Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / jim cramer weighs in on palo alto eli lilly and sale mwn benzinga


TECH - Jim Cramer Weighs In On Palo Alto Eli Lilly And Salesforce Says Price Target Bump For This Stock A 'Red Flag' | Benzinga

During Tuesday’s CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market themes. Cybersecurity emerged as a key focus, with Jim Cramer emphasizing heightened threats following a recent breach at UnitedHealth.

What Happened: Cramer advocated for an aggressive long position in Palo Alto Networks Inc (NASDAQ:PANW) citing the growing demand for cybersecurity solutions amid escalating threats. The increasing prevalence of high-profile incidents underscores the significance of robust cybersecurity measures, reported CNBC.

Eli Lilly And Co (NYSE:LLY) faced stock declines as Viking Therapeutics Inc (NASDAQ:VKTX) presented promising results for its GLP-1 treatment, a potential rival. Cramer addressed concerns, highlighting the importance of substantial backing from pharmaceutical companies for market dominance. "Without the major backing of a pharmaceutical company, it's not enough [to beat out Eli Lilly,]" he said

Wells Fargo raised its price target on Salesforce Inc (NYSE:CRM) shares ...

Full story available on Benzinga.com

Stock Information

Company Name: Bio-Techne Corp
Stock Symbol: TECH
Market: NASDAQ
Website: bio-techne.com

Menu

TECH TECH Quote TECH Short TECH News TECH Articles TECH Message Board
Get TECH Alerts

News, Short Squeeze, Breakout and More Instantly...